Latest News & Features
Careers
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market. 4 June 2024
.jpg/r%5Bwidth%5D=1280&r%5Bheight%5D=720/be560b60-1ea2-11ef-9b6f-6f7457ee66c6-Shutterstock_1733258012%20(3).webp)
Medtech
University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging. 30 May 2024
Americas
International Health Brands takes aim at former COO alleging trade secret theft of ingredients in immunity gummies | Accusations include deceptive marketing strategies, infringement, unfair competition, and misappropriation of trade secrets. 30 May 2024
Europe
WIPO member states approve treaty addressing IP issues related to genetic resources and traditional knowledge | Agreement marks new era for IP rights and Indigenous Peoples, introducing international legal requirements for patent applicants. 28 May 2024
Americas
US and Indian firms reach agreement to settle US litigation and UK arbitration | HDT had accused Emcure of trade secrets theft over COVID-19 vaccine technology. 28 May 2024
Big Pharma
US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator. 23 May 2024
Careers
The patent attorney’s expertise spans artificial intelligence, machine learning and medical devices. 23 May 2024
Biotechnology
New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that Pfizer’s Comirnaty vaccine did not infringe patents. 23 May 2024
Biotechnology
ARP maintained rejection of two claims of Xencor’s antibodies patent application | Panel clarified specification for means-plus-function claim limitations. 21 May 2024
Biotechnology
Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains steadfast in defending its innovations. 21 May 2024